Get started
Author

Nada Božina

Observed name: Nada Bozina
OpenAlex ID: A5103801748
Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients
2006 · Nada Bozina, Vesna Medved, et al. · Journal of Psychopharmacology · 45
Pharmacogenetics and antipsychotics in the light of personalized pharmacotherapy.
2010 · Alma Mihaljević-Peles, Marina Sagud, et al. · PubMed · 13
PDF
Challenging pharmacotherapy management of a psychotic disorder due to a delicate pharmacogenetic profile and drug-drug interactions: a case report and literature review
2024 · Andrej Belančić, Aristea Pavešić Radonja, et al. · Croatian Medical Journal · 5
PDF
Association of serotonin transporter gene (SERT) polymorphisms with Crohn's disease (CD) phenotypes
2013 · Katja Grubelić Ravić, Marko Brinar, et al. · 1
[Adverse drug reactions of hydroxymethylglutaryl-CoA reductase inhibitors reported to agency for medicinal products and medical devices].
2010 · Nikica Mirosević Skvrce, Nada Bozina, et al. · PubMed · 1
Rosuvastatin-induced rhabdomyolysis – the possible role of ticagrelor and the patient’s pharmacogenetic profile: a case report
2018 · Iva Ladić, Majda Vrkić Kirhmajer, et al. · Cardiologia Croatica
PDF
ABCG2 and CYP3A4 polymorphisms as a risk factors for developing adverse drug reactions in patients taking atorvastatin: a case-control study
2015 · Nikica Mirošević Skvrce, Lana Ganoci, et al.
Clopidogrel dose adjustment in acute coronary syndrome and initial high on-treatment platelet reactivity – can we overcome reduced activity of isoenzyme CYP2C19?
2014 · Jure Samardzic, Nada Bozina, et al. · Cardiologia Croatica
PDF
Influences of polymorphisms in the serotonin transporter gene on the behaviour of Crohn's disease
2014 · Silvija Ćuković-Čavka, Katja Grubelić Ravić, et al.
: pharmacogenetics; drug toxicity; cytochrome P-450 enzyme system; TPMT; genetic testing
2013 · Nada Božina, Lana Pejnović · Paediatria Croatica
PDF
Pharmacogenomics and inflammatory bowel disease
2013 · Silvija Ćuković-Čavka, Nada Božina
Inosine triphosphate pyrophosphatase and xanthine oxidase gene variability in Croatian inflammatory bowel disease patients
2013 · Marijana Cota, Silvija Ćuković-Čavka, et al.
Farmakogenomika i upalne bolesti crijeva
2013 · Silvija Ćuković-Čavka, Nada Božina
ABCG2 gene variant and fluvastatin adverse drug reactions in renal transplant recipients
2012 · Nikica Mirošević Skvrce, Nada Božina, et al. · Biochemia Medica
Association study of weight gain and treatment response with 5HT2C gene polymorphism in female schizophrenic patient
2011 · Martina Rojnić Kuzman, Nada Božina, et al. · The World Journal of Biological Psychiatry
Response to corticosteroid therapy and allelic variants of the multidrug resistance gene (MDR1/ABCB1) in patients with Crohn's disease
2011 · Silvija Čuković Čavka, Nada Božina, et al.
Nuspojave inhibitora 3-hidroksi-3-metil-glutaril koenzim A reduktaze prijavljene agenciji za lijekove i medicinske proizvode
2010 · Nikica Mirošević Skvrce, Nada Božina, et al. · University of Zagreb University Computing Centre (SRCE)
PDF
Serotonin transporter gene polymorphisms in Crohn's disease patients
2009 · Katja Grubelić Ravić, Silvija Čuković Čavka, et al.
Adiponectin serum concentrations in dyslipidemic subjects with small dense LDL particles
2009 · Željka Vogrinc, Hana Ljubić, et al.
Adiponectin and small LDL particles
2009 · Željka Vogrinc, Hana Ljubić, et al.
Adiponektin i male LDL čestice
2009 · Željka Vogrinc, Hana Ljubić, et al.
Azathioprine-induced allergic hepatitis associated with thiopurine methyltransferaze (TPMT)genotype
2007 · Silvija Ćuković-Čavka, Nada Božina, et al.
Molecular biology methods in medicine
2005 · Draško Šerman, Zdravko Lacković, et al.
Works count: 23
Citation count: 65
H-index: 3
I10-index: 2
Year
Topic
Type